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ABSTRACT
Objective: The present study was investigated to determine the correlation of body mass index (BMI) with thyroid-stimulating hormones (TSH) in 
thyroid patient.
Methods: The data which are used in this study were taken in Tagore Hospital and Heart Care Centre (Jalandhar). A total of 90 volunteers both 
males and females in the age group between 17 and 85 years were included in this study. The following information taken on pro forma such as age 
in years, height (cm), weight (kg), and history (including: Chief complaints, family thyroid history, blood pressure, temperature, and head and neck 
examination) from the subjects were collected. Serum T3, T4 and TSH test are performed by the use of instrument ADVIA Centaur@CP Immunoassay 
System (SIEMENS). The total data were divided into three groups named as: Subclinical hypothyroid (SH) (n=30), euthyroid (n=57), and hyperthyroid 
including only three patients, and according to age, weight (kg), height (m2), and BMI, the mean±standard deviation (S.D) values were calculated. The 
BMI is calculated with the formula given by the WHO.
Results: For correlation analysis, according to total male and female population in euthyroid group, the mean and SD values of TSH and BMI were 
calculated. Maximum values of T3 (4.7) and T4 (22.1) in hyperthyroid and TSH (9.9) in SH group were found. The high mean values of T3 (2.92) and 
T4 (18.46) in hyperthyroid and TSH (29.1) in SH group were observed. Low mean values of T3 (0.97) and T4 (7.7) in SH and low mean TSH (0.04) in 
hypothyroid group were noticed.
Conclusion: Based on the data analysis, it can interpreted that a poor positive correlation between TSH and BMI and poor negative correlation 
between TSH and BMI are associated in euthyroid subjects. It indicates that, when TSH increases, the BMI will also be increased in total and female 
euthyroid subjects.
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INTRODUCTION
The thyroid is an endocrinal, butterfly-shaped, and biggest gland in the 
neck which makes and stores hormones that help in the regulation of 
blood pressure, heart rate, and body temperature and also help in the 
regulation of growth and rate of chemical reactions (metabolism) in the 
body. The thyroid gland made up from follicular cells which produce 
two major hormones of the thyroid gland - T3 (triiodothyronine) and T4 
(tetraiodothyronine or thyroxine) and few parafollicular cells (C - cells) 
produces hormone called “Calcitonin” which helps in the regulation of 
calcium homeostasis [1-3]. Higher amount (80–95%) of T4 is formed, 
but it is biologically less active, and T3 is found in less amount (about 
5–20%) biologically more active than T4 [4]. Thyroid gland cells have 
receptor site, thyroid-stimulating hormones (TSH) secreted by anterior 
pituitary linked with these receptors, and the cells stimulated to 
produce and release thyroid hormones. If more T3 and T4 are required 
to the body, then more amount of TSH is produced, and if less T4 and T3 
are required, then small amount of TSH is produced by pituitary gland 
[5]. TSH regulates the iodide uptake by sodium/iodide symporters; the 
steps are necessary for normal thyroid hormone synthesis and secretion 
[6]. In circulation majority of T4 and T3 bound with carrier proteins, 
such as Thyroxine binding proteins (TBG), having higher affinity for 
T4, thyroxine binding prealbumin (transthyretin) and albumin, which 
helps in transportation [7]. Only a small fraction remains unbound 
known as free T3 (fT3) and free t4 (fT4) in the circulation, and when 
it reached into the required tissue, it enters inside the cells by unique 
transport channels and cytoplasm is the site where conversions of T4 
to T3 take place, mainly in liver, pituitary gland, kidney, and peripheral 
tissue. Normally, about 0.03% T4 and 0.5% T3 were found in unbound 
form, and only free form has the ability to bind with specific hormone 
receptor in peripheral tissue [8].
Hypothyroidism, hyperthyroidism, thyroiditis, goiter, nodes, and tumor 
of thyroid gland are the common diseases which are related to thyroid 
gland [9]. Hypothyroidism is a clinical syndrome resulting from the 
deficiency of thyroid hormones which leads to slow down the metabolic 
processes [10]. The cases of thyroid failure were most commonly 
observed in women’s and incidence is increased with age [11]. 
Autoimmune chronic lymphocytic thyroiditis is the most common cause 
of hypothyroidism in Australia. It is commonly seen in diabetic patients 
[12,13]. It is obesity like pathological condition, associated with lipid 
metabolism disorders, and leads to dyslipidemia (one of the major 
risk factors of coronary diseases) [14]. Hypothyroidism is associated 
with cardiovascular risk factors, and if remains untreated, it can lead 
to atherosclerosis [15]. Subclinical hypothyroidism (SH) is defined as 
abnormal condition which appears with mild elevated TSH level (5–
10 mIU/L), normal thyroid hormones concentration with no clinical 
signs and symptoms. It is estimated that 4.3–9% of general population 
was affected with SH [16,17]. Effect of SH is not well understood yet, 
but various studies reported that it is associated with high levels of low-
density lipoprotein (LDL), total cholesterol (TC), and cardiovascular 
disease patients [18]. Among the childrens, autoimmune thyroiditis 
is the most common cause of SH and diagnosed by elevated levels of 
serum thyroid peroxidase. Overt hypothyroidism was diagnosed by 
decreased serum fT4 with increased TSH levels. Overt hypothyroidism 
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is associated with hypercholesterolemia. Previous studies suggested 
that patients with overt hypothyroidism have more risk of developing 
atherosclerotic disease. The well-documented features of overt 
hypothyroidism are high levels of apolipoprotein B, LDL cholesterol, 
and total cholesterol [19,20]. Therefore, the catabolism of LDL and 
intermediate density lipoprotein is decreased because the activity of 
LDL receptors decreased and [21]. An elevated homocysteine level is a 
risk factor for cardiovascular disease (CVD), and its levels are reported 
to be increased in overt hypothyroidism. Hyperthyroidism also called 
thyrotoxicosis caused by the overproduction of thyroid hormones. The 
prevalence found more in women (2%) than men (0.2%), and 15% 
of cases of hyperthyroidism occurs in patient older than 60 years. In 
iodine-sufficient areas, the prevalence of overt hyperthyroidism is 2 
per 1000 and subclinical hyperthyroidism is 6 per 1000 [22]. In general 
population, the incidence of hyperthyroidism is lower (2.2%) as 
compared to hypothyroidism [23]. The symptoms of hyperthyroidism 
vary according to the age, amount of T3 and T4 you have, and how long 
your thyroid gland produces excess T3 and T4. It mainly appears with 
symptoms of sympathetic nervous system. Young patients may suffer 
with anxiety, tremor, and hyperactivity, and older patients have more 
cardiovascular symptoms including dyspnea, atrial fibrillation, and 
weight loss [24].
METHODS
The present study was carried out in Tagore Hospital and Heart Care 
Center (Jalandhar). A total of 90 volunteers both males and females in 
the age group between 17 and 85 years were included in this study. 
Age in years, height (cm), weight (kg), and history (including chief 
complaints, family thyroid history, blood pressure, temperature, and 
head and neck examination) from the subjects were collected.
Exclusion criteria 
Smokers and alcoholic were excluded from the study.
Blood sample collection
From all the subjects who came for the determination of thyroid 
profile, the blood samples with record of age and sex were collected. 
By venepuncture method, approximately 5 ml blood was collected 
in plain vial from all subjects, and after centrifugation, the serum 
sample was analyzed for quantitative estimation of T3, T4, and TSH 
levels. The estimation of T3, T4, and TSH in human Serum was done 
by Autoanalyzer named as “ADVIA Centaur@CP Immunoassay System” 
(SIEMENS) based on “Sandwich principle.”
Reference Range:
The reference range is as follows:
T3 - 0.60–1.81 ng/ml.
T4 - 3.20–12.6 ug/ml.
TSH - 0.35–5.0 uIU/ml.
Anthropometrical measurements
An instrument named as stadiometer was used to measure height (m) 
and standard weighing machine used for weight. The body mass index 
(BMI) was calculated using formula.








BMI is classified as follows: <18.5 - underweight, 18.5–24.9 - normal 
weights, >25.0 - overweight, >30.0 - overweight, 30.0–34.9 - obese 
Class I, 35.0–39.9 - obese Class II, and >40.0 - obese Class III (according 
to the WHO).
Biochemical analysis
Thyroid profile assay (T3, T4, and TSH) was performed using instrument 
- ADVIA Centaur@CP Immunoassay System (SIEMENS).
Principle of ADVIA Centaur@CP immunoassay system (SIEMENS)
Chemiluminescence is a chemical reaction that emits energy in the 
form of light, and when used with immunoassay technique, the light 
produced by the reaction indicates the amount of analyte in a sample.
In CLIA, microplate luminometers are used which give a sensitive, easy, 
and alternative to conventional colorimetric methods (ELISA). The 
technique (ELISA) is based on colorimetric reactions of chromogenic 
substrates (e.g., TMB) and label enzymes. CLIA provides high 
sensitivity over the conventional colorimetric methods in terms of less 
incubation time and the use of stopping reagents. The CLIA involves a 
horseradish peroxidase-labeled antibody or antigen and a mixture of 
chemiluminescent substrate, hydrogen peroxide, and enhancers. CLIA 
kits are designed to detect chemiluminescent reactions. The method is 
highly sensitive for T3, T4, and TSH estimation.
RESULTS
The present study was conducted on a total of 90 individuals. Both males 
and females in the age group between 17 and 81 years were included 
in this study. First, the total data were divided into three groups named 
as follows: Subclinical hypothyroid (n=30), euthyroid (n=57), and 
hyperthyroid including only three patients, and according to age, weight 
(kg), height (m2), and BMI, and the mean±S.D values were calculated.
As a comparison between three groups, minimum values of T3 (0.60) 
in euthyroid, T4 (4.1) in SH, and TSH (0.01) in hyperthyroid were 
observed. Maximum values of T3 (4.7) and T4 (22.1) in hyperthyroid 
and TSH (9.9) in SH group were found. The high mean values of 
T3 (2.92) and T4 (18.46) in hyperthyroid and TSH (29.1) in SH group 
were observed. Low mean values of T3 (0.97) and T4 (7.7) in SH and 
low mean TSH (0.04) in hypothyroid group were noticed.
For correlation analysis, according to total, male, and female population 
in euthyroid group, the mean and standard deviation values of TSH 
and BMI were calculated and placed into the Tables 1-3. Correlation 
coefficient (r value) for total, male, and female were calculated in 
Microsoft Office Excel Worksheet using (Data Analysis) correlation 
formula. The correlation coefficient (r – value) lies from −1 to +1.
Tables 4 and 5 show poor positive relationship between TSH and BMI 
in euthyroid (total) that means that, if one variable increases, the other 
variable also increases, or if one decreases, other will also decrease. In 
males, poor negative correlation (means one variable increases and 
other variable decreases or vice versa) and in females poor positive 
relation were observed in euthyroid group. In SH group, poor negative 
correlation was found in total, male, and female population.
DISCUSSION
The present study was undertaken to find the association between TSH 
and BMI in subclinical hypothyroid patients and euthyroid individuals. 
This study includes a total of 90 individuals that categorized into three 
groups (as euthyroid, subclinical hypothyroid, and hyperthyroid) 
according to their T3, T4, and TSH levels. The normal range for thyroid 
profile is as follows:
T3 - 0.60–1.80 ng/ml.
T4 - 3.20–12.6 ug/ml.
TSH - 0.35–5.0.
In total, euthyroid subjects include 57 numbers, subclinical hypothyroid 
include 30, and hyperthyroid include only 3 patients. In our study, 
we found a high prevalence of thyroid diseases in females (n=66%) 
than males (n=24%). Various previous studies observed that thyroid 
hormones can affect the body weight by altering the basal metabolic 
rate. Some studies show decreased thyroid functions associated with 
weight gain or obesity, and other analysis shows no relation with 
this regard. The link between body weight and TSH level is especially 
attractive.
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In previous studies, it was found that association between TSH and BMI 
could be altered by smoking, but in recent studies, a positive correlation 
within BMI and TSH was observed in smokers. A study conducted by 
Knudsen et al. (2005) noticed that little changes in thyroid function are 
associated with alteration in BMI, but the exact mechanism about this 
association is not clear. The obesity is defined by BMI (>25), and most 
of the patients were found to obese who came for the assessment of 
thyroid functions in the hospital.
Obesity is appeared with alterations in lipid parameters which 
further leads to CVD. The decrease functions of thyroid gland 
are related to obesity, and it was suggested that there must be 
association lying between lipid profile and thyroid hormones. 
Various studies were conducted to find the relationship between 
TSH and lipid profile but yet they do not observed any clear 
relationship.
A recent study performed by Laway et al. in 2014 was to evaluate 
the variations in lipid parameters between subclinical hypothyroid, 
and normal individuals were observed the 39 elevated levels of TC, 
triglycerides, and very low-density lipoprotein (VLDL) in patients with 
SH. No relationship was observed between HDL and TSH.
In the present study, the poor positive correlation (r value - 0.14) 
between TSH and BMI was observed in total euthyroid subjects. A poor 
negative association was observed between TSH and BMI in males and 
poor positive (r value – 0.21) relationship was observed in euthyroid 
females (shows in Table 4). Suganty et al. (2011) were reported that 
there was a significant positive correlation between serum TSH and BMI 
in euthyroid females. Deiz et al. also noticed a significant correlation 
between TSH and BMI in euthyroid subjects. They conclude that TSH 
level significantly increased with weight.
In SH patients (total, male, and female), poor negative correlation was 
observed between TSH and BMI (Table 5). This indicates that the vice 
versa relationship lies between TSH and BMI in SH patients. The SH 
also called mild thyroid failure is defined as a normal thyroid hormones 
but mildly elevated TSH (5 – 10 uIU/ml) with no or mild sign and 
symptoms. The mild symptoms include weight gain, memory problems, 
and cold intolerance. In the present study, the prevalence of weight 
gain, less sleep, and joint pain observed more in SH patients.
Patients with SH have a higher risk of CVD then euthyroid. The 
occurrence of SH was found significantly higher in female population. 
The information about “correlation between TSH and BMI in SH 
patients” is very less or not well understood. Prasad et al. in 2013 
observed a statistically significant difference between male and female 
patients with SH. They conclude that the TSH levels were significantly 
higher in morbidly obese female’s patients than in males.
The exact mechanism behind the increased TSH in obese person not 
clears properly and it is more difficult to find mild thyroid failure in 
obese persons. In obese adults and children’s, elevated TSH appeared 
Table 1: The general data with values (mean±S.D) of age, weight (kg), height (m2), and BMI in three groups
Parameter Subclinical hypothyroid (n=30) Euthyroid (n=57) Hyperthyroid (n=3)
Age (years) 48.6±15.8 52.0±12.5 47.3±11.0
Weight (Kg) 74.3±16.7 70.4±11.5 73.3±2.8
Height (m2) 2.67±16.7 2.68±0.3 2.72±0.2
BMI (Kg/m2) 27.7±5.8 26.3±4.6 27.0±2.9
The values (mean±S.D) of various parameters including thyroid profile, BMI, and weight were distributed according to the age groups. BMI: Body mass index
Table 2: The status of various parameters including thyroid profile (T3, T4, and TSH), BMI, and weight according to different age groups
Age group (years) n T3 (ng/ml) T4 (ug/ml) TSH (uIU/ml) BMI (m) Weight (kg)
17–30 7 1.13±0.37 7.31±2.66 5.28±3.36 24.32±4.83 65.71±11.94
31–40 13 1.24±1.06 8.96±4.46 4.40±3.07 26.8±4.68 70.46±16.09
41–50 25 1.05±0.34 8.77±2.77 3.66±2.77 28.81±5.72 75.6±14.73
51–60 23 1.11±0.31 9.58±2.89 3.20±2.04 26.27±4.63 72.21±13.29
61–70 18 1.04±0.34 8.35±2.27 3.79±2.76 26.51±4.94 69.72±10.51
>70 4 0.97±0.20 9.45±1.87 7.59±2.29 23.8±0.96 70.5±7.72
BMI: Body mass index, TSH: Thyroid-stimulating hormones
Table 3: The minimum, maximum, average, and SD values of thyroid profile (T3, T4, and TSH) in all three groups (S.H, euthyroid, and 
Hyperthyroid)
Parameter SH (n=30) Euthyroid (n=57) Hyperthyroid (n=03)
T3 (ng/ml) T4 (ug/ml) TSH (uIU/ml) T3 (ng/ml) T4 (ug/ml) TSH (uIU/
ml)
T3 (ng/ml) T4 (ug/
ml)
TSH (uIU/ml)
Min 0.66 0.41 5.03 0.60 4.4 0.54 1.99 15.1 0.01
Max 1.63 12.5 9.9 1.86 12.5 4.94 4.7 22.1 0.11
Mean 0.97 7.7 7.39 1.07 8.89 2.39 2.92 18.46 0.04
SD 0.25 2.56 1.58 0.29 2.14 1.15 1.53 3.50 0.05
SH: Subclinical hypothyroid, SD: Standard deviation
Table 4: The correlation of TSH and BMI in euthyroid subjects
Sex n TSH (Ulu/ml BMI (Kg/m2) r value Correlation
Total 57 2.39±1.51 26.37±4.67 0.14 Poor positive
Male 14 2.48±1.35 26.01±4.29 −0.05 Poor negative
Female 43 2.36±1.09 26.48±4.82 0.21 Poor positive
BMI: Body mass index, TSH: Thyroid-stimulating hormones
Table 5: The correlation of TSH and BMI in subclinical 
hypothyroid patients
Sex n TSH (Ulu/ml BMI (Kg/m2) r value Correlation
Total 30 7.39±1.58 27.71±5.86 −0.05 Poor negative
Male 9 7.36±1.64 26.95±3.90 −0.27 Poor negative
Female 21 7.40±1.54 28.04±6.58 −0.01 Poor negative
BMI: Body mass index, TSH: Thyroid-stimulating hormones
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with enlargement of thyroid gland and hypoechogenicity. Diagnosis of 
hypothyroidism not only evaluated by ultrasound but also the proper 
diagnosis requires blood test with physical examinations.
The hypothyroidism is associated with weight gain or obesity which 
is the major risk factor for diabetes. Found by various researches that 
patients with diabetes may have abnormal thyroid functions. A study 
shows prevalence 18.3% of SH in patients with type 2 diabetes mellitus. 
The prevalence was found more in patients with age more than 50 years.
CONCLUSION
The thyroid hormones play various essential roles in our body, and they 
are essential for normal body functions. They were required to normal 
regulation of myocardial infarction, pulmonary ventilation, energy 
homoeostasis, vascular tone, water and electrolyte balance also helps 
in normal function of the CNS.
Various studies were performed to find the association between TSH 
and BMI and each study gives a different finding in their study. Based 
on the data analysis, it can interpreted that a poor positive correlation 
between TSH and BMI and poor negative correlation between TSH and 
BMI are associated in euthyroid subjects. It indicates that, when TSH 
increases, the BMI will also be increased in total and female euthyroid 
subjects. Inverse or poor negative correlation was observed within TSH 
and BMI in patients with SH.
In the future, further studies regarding “correlation between BMI and 
TSH” will defiantly add an account in the previous study. Therefore, 
from the literature available and statistical analysis of the data, it is 
accepted and state as there is a positive correlation associated between 
BMI and TSH in euthyroid subjects (total and female).
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